Allogeneic Chimeric Antigen Receptor T Cells for Children with Relapsed/Refractory B-Cell Precursor Acute Lymphoblastic Leukemia

The authors summarize the current pre-clinical and clinical approaches based on allogeneic CAR T cells, as well as on alternative effector cells, which represent exciting opportunities for multivalent approaches and optimized antitumor activity.
Full Article